Novel biologics sustainably sourced from microalgae and cyanobacteria

Building A More Circular Future

Our vision is to build a global, vertically integrated business commercialising novel compounds extracted from Cyanobacteria and Microalgae.

The wide range of compounds found within the many thousands of strains of these miraculous microorganisms, offers the opportunity to build a circular industry to replace today’s less sustainable methods of production across almost all industry sectors.

Simris Biologics

Identifying novel natural products and developing technology platforms to turns these into products that transform lives.

© 2024 Simris Group · Pioneering algae biotech since 2011. all rights reserved.

Simris Alg AB shares are traded on the Nasdaq First North Growth Market with the short name SIMRIS and ISIN code SE0008091664. Certified Adviser is Amudova AB, telephone: +46 8 546 017 58, email: